Perrigo Ends 2017 As It Started: Earnings Results Delayed

The OTC drug, nutritional products and Rx generics manufacturer reported interim and unaudited results for 2017 and said it will release its entire earnings statement on a date yet to be determined because "it needs additional time to complete its final income tax review procedures related to reconciliations of specific non-cash items.2018 begins with new CEO Uwe Rohrhoff at the helm.

Business time concept as a group of running businessmen and businesswomen using a giant clock to cross over a cliff as a bridge as a metaphor for schedule and appointment speed as a 3D illustration.

Perrigo Co. PLC ended 2017 as it began the year, with its latest quarterly earnings results delayed. It put its fourth-quarter results on hold to figure out its taxes while its first-quarter results were delayed to restate some revenues.

The OTC drug, adult and infant nutritional products and Rx specialty topical generics manufacturer on Feb. 27 reported interim and...